Catch the latest health news: ACSH’s Ariel Savransky attends an e-cig conference along with industry leaders and public officials, GM labeling benefits no one, except the organic food industry, and why public officials are seeking more transparency when it comes to data from medical trials.
Yesterday, ACSH’s Ariel Savransky attended the 2nd Annual E-cig conference in New York City. Conference attendees included investors, industry leaders and public health and regulatory experts and discussion was Continue reading →
In today’s “you could have predicted this” department, we are going to take a look back at the rather naive mindset of the American public that took center stage about five years ago.
At that time, the pharmaceutical industry was facing the “patent cliff”— the loss of the patent life of some of the best selling drugs. Once the patent of the original discovery expires, any company is then free to manufacture the generic version of the same drug the next day. Continue reading →
Yesterday, the House of Representatives passed two bills aimed at “reforming” the Environmental Protection Agency (EPA). One targeted “secret science”: their standard procedure of using data immune from review and replication. Not acceptable. Continue reading →
Tomorrow is the 39th annual Great American Smokeout, sponsored by The American Cancer Society. Given the dramatic (lack of) success of getting America’s 42 million smokers to quit, maybe it should be the Great American VAPE-out? Continue reading →
Last Wednesday, the town of Westminster, MA attempted to hold a public hearing to discuss the proposal to ban the sale of products containing tobacco or nicotine, including cigarettes, chewing tobacco, and electronic cigarettes. However, chairwoman Andrea Crete was forced to call the session to an end, as attendees became Continue reading →